Signaturefd, LLC Autolus Therapeutics PLC Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.04 - $4.68 $705 - $1,619	-346 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$3.52 - $5.46 $2,942 - $4,564	-836 Reduced 70.73%	346 $1,000
Q4 2021 Jan 25, 2022	SELL	$5.1 - $7.0 $11,964 - $16,422	-2,346 Reduced 66.5%	1,182 $6,000
Q3 2021 Oct 28, 2021	BUY	$5.32 - $7.37 $16,555 - $22,935	3,112 Added 748.08%	3,528 $23,000
Q2 2021 Jul 26, 2021	BUY	$4.78 - $7.96 $1,988 - $3,311	416 New	416 $3,000

Q2 2020 Jul 30, 2020	SELL	$5.38 - $16.14 $2,776 - $8,328	-516 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$4.2 - $13.0 $2,167 - $6,708	516 New	516 $3,000

123

168M

411K

67.6K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $316M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.